(NASDAQ: VANI) Vivani Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.47%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.84%.
Vivani Medical's earnings in 2024 is -$23,462,000.On average, 1 Wall Street analyst forecast VANI's earnings for 2024 to be -$24,286,222, with the lowest VANI earnings forecast at -$24,286,222, and the highest VANI earnings forecast at -$24,286,222.
In 2025, VANI is forecast to generate -$24,286,222 in earnings, with the lowest earnings forecast at -$24,286,222 and the highest earnings forecast at -$24,286,222.